The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment. (Q40605234)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

12

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

2

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

11

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

8

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

5

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

10

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

9

Satoshi Saitoh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

3

Mariko Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

7

Takashi Someya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Akihito Tsubota

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

315-321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Hepatitis B genotypes and the response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Clinical implications of lamivudine resistance by HBV

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Long-term therapy of chronic hepatitis B with lamivudine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

Hepatitis B viral genotypes and lamivudine resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900410-5

7 January 2021

10.1016/S0168-8278(02)00410-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12586297%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference